Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0225
0.00 (0.00%)
Sep 26, 2024, 11:00 AM EDT
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $9.04 million as of September 26, 2024. Its market cap has decreased by -14.33% in one year.
Market Cap
9.04M
Enterprise Value
20.92M
Revenue
70.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has decreased from 9.14M to 9.04M, a decrease of -1.13%. That is a compound annual growth rate of -0.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 25, 2024 | 9.25M | -39.44% |
Dec 29, 2023 | 15.27M | -13.24% |
Dec 30, 2022 | 17.60M | -71.94% |
Dec 31, 2021 | 62.72M | 225.64% |
Dec 31, 2020 | 19.26M | 34.48% |
Dec 31, 2019 | 14.32M | 56.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 18.05B |
Telix Pharmaceuticals Limited | 4.81B |
Elekta AB (publ) | 2.52B |
Ryman Healthcare Limited | 1.83B |
Verano Holdings Corp. | 1.22B |
Medexus Pharmaceuticals Inc. | 47.39M |